相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
Rosa Nguyen et al.
NEOPLASIA (2022)
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
Xiaojun Yuan et al.
CELL REPORTS (2022)
MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation
Jolien De Wyn et al.
CANCERS (2021)
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
Selina Jansky et al.
NATURE GENETICS (2021)
Future prospects for mitosis-targeted antitumor therapies
Alfonso Serrano-del Valle et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors
O. C. Bedoya-Reina et al.
NATURE COMMUNICATIONS (2021)
Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma
Isabelle Roeschert et al.
NATURE CANCER (2021)
Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma
Rui Dong et al.
CANCER CELL (2020)
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi et al.
CANCER RESEARCH (2018)
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis
Carmen Dorneburg et al.
CLINICAL CANCER RESEARCH (2018)
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Rhamy Zeid et al.
NATURE GENETICS (2018)
In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
Suzanne Vanhauwaert et al.
SCIENTIFIC REPORTS (2018)
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
Steven G. DuBois et al.
CLINICAL CANCER RESEARCH (2018)
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen et al.
NATURE GENETICS (2017)
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
Valentina Boeva et al.
NATURE GENETICS (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination
Jungoh Ham et al.
CANCER CELL (2016)
Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis
Daniel R. Carter et al.
MOLECULAR ONCOLOGY (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
Johannes Fabian et al.
ONCOTARGET (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
MYC Is a Major Determinant of Mitotic Cell Fate
Caroline Topham et al.
CANCER CELL (2015)
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
Anneleen Beckers et al.
CANCER LETTERS (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
Dominik Bogen et al.
ONCOTARGET (2015)
MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation
Anneleen Beckers et al.
ONCOTARGET (2015)
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
Charles Wang et al.
NATURE BIOTECHNOLOGY (2014)
The prenatal origins of cancer
Glenn M. Marshall et al.
NATURE REVIEWS CANCER (2014)
Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice
P. N. Kelly et al.
CELL DEATH AND DIFFERENTIATION (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation
M. Calao et al.
ONCOGENE (2013)
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
H. Kocak et al.
CELL DEATH & DISEASE (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
Andrew W. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation
Hongkai Ji et al.
PLOS ONE (2011)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann et al.
GENOME BIOLOGY (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Analysis of apoptosis by propidium iodide staining and flow cytometry
Carlo Riccardi et al.
NATURE PROTOCOLS (2006)
Mechanisms of embryonal tumor initiation:: Distinct roles for MycN expression and MYCN amplification
LM Hansford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
